NEW YORK (AP) – Drug developer Pfizer Inc. said Thursday the Food and Drug Administration approved its drug Lyrica as a treatment for fibromyalgia, a widespread and chronic pain condition.
The drug is already approved as a diabetic nerve pain treatment. During the first quarter, Lyrica sales reached $395 million.
Pfizer said about 6 million Americans have fibromyalgia, which is characterized by chronic widespread pain and can cause poor sleep, stiffness and fatigue.
Shares of Pfizer rose 23 cents to close at $25.94.
————
Questions or comments about this story should be directed to Damian J. Troise at 212-621-7190
Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Bitcoin 
Ethereum 
XRP 
Tether 
BNB 
Solana 
USDC 
Cardano 
Lido Staked Ether 
TRON 
Avalanche 
Toncoin